Table 3. Comparison between Patients with Periaortic VT and Controls Table 3. Comparison between Patients with Periaortic VT and Controls Table 3. Comparison between Patients with Periaortic VT and Controls Table 3. Comparison between Patients with Periaortic VT and Controls
Periaortic VT group (N=3) Control group (N=106)
P-value
Type of aortic valve (mechanical valve) 2(66) 58(54) 1.0
Primary aortic valve diseases
AS 1(33) 61(57) 0.6
AR 1(33) 27(25) 1.0
IE 1(33) 17(16) 0.4
Periods after AVR (years) 12.3±6.7 10.9±8.5 0.8
Male 3(100) 62(58) 0.3
Age (years) 78.0±3.6 73.3±14.1 0.6
BMI (kg/cm2) 23.8±2.2 22.2±4.2 0.5
HT 2(67) 65(61) 1.0
DL 2(67) 51(48) 0.6
DM 0(0) 26(24) 1.0
CKD 2(67) 53(50) 1.0
Hemodialysis 0(0%) 5(5%) 1.0
Medication
Beta blocker 2(67) 60(57) 1.0
ACEI/ARB 1(33) 39(37) 1.0
Aldsterone antagonist 0(0) 9(8) 1.0
Amiodarone 1(33) 6(6) 0.2
Antiarrhythmic drug group 1 0(0) 3(3) 1.0
Paroxysmal atrial fibirillation 0(0) 9(8) 1.0
Persistent atrial fibrillation 0(0) 16(15) 1.0